GLP-1 agonists and risk of suicidal thoughts and behaviours: Confound by indication once again? A narrative review
Open Access
- 27 July 2024
- journal article
- review article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 87, 29-34
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Lifetime Suicide Attempts in Otherwise Psychiatrically Healthy IndividualsJAMA Psychiatry, 2024
- Long-Term Brain Structure and Cognition Following Bariatric SurgeryJAMA Network Open, 2024
- Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19JAMA, 2023
- The critical distinction between suicidal ideation and suicide attemptsWorld Psychiatry, 2021
- Association of Borderline Personality Disorder Criteria With Suicide AttemptsJAMA Psychiatry, 2021
- Risk of Suicide and Self-harm Is Increased After Bariatric Surgery—a Systematic Review and Meta-analysisObesity Surgery, 2018
- Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and DepressionJAMA, 2016
- Self-harm Emergencies After Bariatric SurgeryJAMA Surgery, 2016
- GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trialDiabetologia, 2016
- Antidepressant Drug Therapy and Suicide in Severely Depressed Children and AdultsArchives of General Psychiatry, 2006